NYU Cancer Institute New York University Langone Medical Center New York, New York
The NYU Cancer Institute (NYUCI) was founded in 1975 and received its NCI designation that year. The Center was named the Rita J. and Stanley H. Kaplan Cancer Center in 1983. In 1991, the NYU Cancer Center in New York City and the Cancer Center at the Nelson Institute of Environmental Medicine merged.
The NYUCI’s mission is to discover the origins of human cancer and to use that knowledge to eradicate the personal and societal burden of cancer. The Institute is a translational cancer center, taking a team approach to cancer. The over 250 members of the Institute come together from a variety of disciplines to create collaborative research endeavors and clinical care teams.
NYUCI’s scientific research programs focus on either fundamental questions about the biology of cancer or disease-specific research questions centered on individual types of cancer. Current research programs include cancer immunology, environmental and molecular carcinogenesis, growth control, epidemiology and cancer control, stem cell biology, breast cancer, genitourinary cancer, hematologic malignancies, melanoma, gastrointestinal cancers, sarcoma, and thoracic cancer. These research areas are collaborations across medical and scientific disciplines. Their research findings are translated into improved and comprehensive care for patients.
NYUCI operates within the larger New York University (NYU) Medical Center. It draws experts from numerous facilities and affiliate institutions for cancer research and patient care. Facilities include the NYU Clinical Cancer Center, the NYU School of Medicine, Tisch Hospital, Skirball Institute, Kimmel Stem Cell Center, Nelson Institute for Environmental Medicine, Smilow Cancer Research Center, Rusk Institute, and the Hospital for Joint Diseases. Affiliate institutions include the Department of Veterans Affairs, Bellevue Hospital Center, and Woodhull Medical Center.
The Institute is engaged in educating future leaders in the fields of cancer research and care. Graduate education and interdisciplinary training take place through the NYU School of Medicine’s Sackler Institute of Graduate Biomedical Sciences.
NYUCI offers a variety of outreach and education programs both for patients as well as nearby communities. Through community seminars, cancer screenings, special programs for diverse populations, and a speakers’ bureau, the Institute educates the communities it serves and makes cancer care and education available to all. NYUCI offers the full range of care, from prevention through diagnosis, treatment, and post-treatment support.
The Institute serves a diverse patient population. Because of this, NYUCI offers special emphasis programs in cancer health care disparities, molecularly targeted therapy, lung cancer, melanoma, and signaling pathways involved in cancer. Researchers at the Institute capitalize on the unique patterns and etiology of disease within this patient population. Through studying and understanding these patterns of disease, researchers at NYUCI have improved the diagnostic and treatment services for all patients.
* This profile was provided by the New York University Cancer Institute.